
Westwater Resources Supports U.S. Department of Commerce Decision on Chinese Graphite Anode Material
CENTENNIAL, Colo.--(BUSINESS WIRE)-- Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company ('Westwater' or the 'Company'), announced today its support of the U.S. Department of Commerce's ('DOC') preliminary determination in the countervailing duty investigation of anode material from the People's Republic of China. The DOC's initial ruling determined that Chinese producers of anode material are receiving unfair government subsidies, and as a result, are now expected to be subject to U.S. import tariffs of up to 721%.
'This important decision by the DOC is another step toward leveling the playing field for U.S. producers,' said Jon Jacobs, Westwater's Chief Commercial Officer. 'We expect this announcement to accelerate off-take agreements with Westwater and to positively affect our ongoing financing efforts. U.S. automaker and cellmaker buyers are increasingly concluding that executing offtake supply agreements with U.S. producers like Westwater is the surest way to avoid import tariffs and is therefore their most economical long-term solution.'
Pursuant to the preliminary determination, select Chinese natural and artificial graphite anode material producers will be subject to U.S. import tariffs of up to 721% in addition to pre-existing Section 301 and reciprocal tariffs already totaling 55%.
The DOC is also conducting a concurrent antidumping investigation into anode materials imports from the People's Republic of China. This investigation is focused on determining whether Chinese producers are selling graphite-based anode materials in the United States at unfairly low prices - thereby harming U.S. producers. A preliminary decision is expected in July, and if the DOC finds sufficient evidence of dumping, it could impose additional duties and broader penalties.
Mr. Jacobs added, 'The outcome of the antidumping investigation is expected to play a critical role in supporting the development of a robust, secure, and fair domestic supply chain for graphite and battery materials, which are vital to U.S. energy independence and national security. For companies like Westwater Resources that are investing in sustainable, U.S.-based production capabilities, these trade actions should help reduce the nation's reliance on foreign supply chains and benefit domestic producers.'
About Westwater Resources, Inc.
Westwater Resources is an energy technology company that is focused on developing battery-grade natural graphite. Westwater Resources' primary project is the Kellyton Graphite Processing Plant that is under construction in east-central Alabama. In addition, Westwater Resources' Coosa Graphite Deposit is the largest and most advanced natural flake graphite deposit in the contiguous United States — and is located across 41,965 acres (~17,000 hectares) in Coosa County, Alabama. For more information, visit westwaterresources.net.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words and phrases such as 'initial,' 'preliminary,' 'important,' 'expect,' 'accelerate,' 'positively impact,' 'ongoing efforts,' 'level the playing field,' 'increasing,' 'surest way,' 'most economical,' 'additional,' 'broader,' 'critical,' 'help reduce,' and other similar words or phrases. Forward looking statements include, among other things, statements concerning: the importance of critical minerals including battery-grade graphite; establishing a graphite industry in the U.S.; tariffs associated with the importation of natural graphite into the U.S. including the percentage of those tariffs and the countries for which tariffs will apply; the Company's business plans for its Kellyton Graphite Processing Plant; and efforts to manage existing off-take agreements or to put new supply agreements into place for the products from that Plant. The Company cautions that there are factors that could cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of the Company; accordingly, there can be no assurance that such suggested results will be realized. Those uncertainties and other factors are discussed in Westwater's Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent securities filings, and they could cause actual results to differ materially from management expectations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
3 Stocks Showing Positive Momentum Despite Trade Tensions
Wall Street may encounter volatility as trade tensions between the United States and China reignite. The United States blamed China for breaching a temporary trade deal, while Beijing accused Washington of failing to support the agreement, a telltale sign that negotiations between the countries have soured. In this uncertain situation, it's challenging to find stocks with strong uptrends, as they are mostly showing modest gains. However, by applying Richard Driehaus's investment strategy, better known as the 'buy high and sell higher' theory, one can discover stocks displaying positive momentum. To that end, Urban Outfitters, Inc. URBN, Phibro Animal Health Corporation PAHC and Strattec Security Corporation STRT are demonstrating positive momentum and defying gyrations in the broader market. Regarding the strategy, Driehaus once said, 'I would much rather invest in a stock that's increasing in price and take the risk that it may begin to decline than invest in a stock that's already in decline and try to guess when it will turn around.' In line with this insight, the American. The Association of Individual Investors ('AAII') considered the percentage 50-day moving average as one of the key criteria before creating a portfolio following Driehaus' philosophy. It is calculated by dividing the numerator (month-end price minus 50-day moving average of month-end price) by the 50-day moving average of the month-end price. Another momentum indicator — positive relative strength — has also been included in this strategy. A positive percentage 50-day moving average indicates that the stock is trading at a price higher than its 50-day moving average level, indicating an uptrend. Moreover, AAII found that Driehaus primarily focuses on strong earnings growth rates and impressive earnings projections to pick potential outperformers. Companies with a strong history of beating estimates are also given importance in this strategy, which was made to provide better returns over the long term. To make the strategy more profitable, we have considered only those stocks that have a Zacks Rank #1 (Strong Buy) and a Momentum Score of A or B. Our research shows that stocks with a Style Score of A or B, combined with a Zacks Rank #1 or 2 (Buy), offer the best upside potential. • Zacks Rank equal to #1 Whether the market is good or bad, stocks with a Zacks Rank #1 have a proven history of outperformance. You can see the complete list of today's Zacks #1 Rank stocks here. • Last 5-year average EPS growth rates above 2% Strong EPS growth history ensures an improving business • Trailing 12-month EPS growth greater than 0 and industry median Higher EPS growth compared to the industry average indicates superior earnings performance • Last four-quarter average EPS surprise greater than 5% Solid EPS surprise history indicates better price performance • Positive percentage change in 50-day moving average and relative strength over 4 weeks Positive percentage change in the 50-day moving average and the relative strength signal uptrend • Momentum Score equal to or less than B A favorable momentum score indicates that it is ideal for taking advantage of the momentum with the highest probability of success. These few parameters have narrowed the universe of more than 7,743 stocks to only six. Here are three of the six stocks: Urban Outfitters offers lifestyle products and services. Urban Outfitters has a Momentum Score of A. The trailing four-quarter earnings surprise for URBN is 29%, on average. Phibro Animal Health is an animal health and mineral nutrition company with operations in the United States, Israel, Brazil, Ireland and internationally. Phibro Animal Health has a Momentum Score of B. The trailing four-quarter earnings surprise for PAHC is 30.6%, on average. Strattec Security primarily markets automotive security and access control products under the VAST Automotive Group brand in North America. Strattec Security has a Momentum Score of B. The trailing four-quarter earnings surprise for STRT is 195.8%, on average. You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Urban Outfitters, Inc. (URBN) : Free Stock Analysis Report Strattec Security Corporation (STRT) : Free Stock Analysis Report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
25 minutes ago
- Yahoo
High Growth Tech Stocks in Asia for June 2025
Amid a backdrop of easing inflation and renewed trade tensions, Asian markets are navigating a complex landscape that has seen smaller-cap indexes in the U.S. lag behind their larger counterparts, yet still manage to post positive returns. In this environment, identifying high-growth tech stocks in Asia requires careful consideration of companies that can leverage technological advancements and strategic positioning to thrive despite global economic uncertainties. Name Revenue Growth Earnings Growth Growth Rating Suzhou TFC Optical Communication 29.68% 30.37% ★★★★★★ Fositek 26.71% 33.90% ★★★★★★ Shengyi Electronics 22.99% 35.16% ★★★★★★ Shanghai Huace Navigation Technology 24.40% 23.42% ★★★★★★ Range Intelligent Computing Technology Group 27.31% 28.63% ★★★★★★ Shanghai BOCHU Electronic Technology 22.41% 23.53% ★★★★★★ Nanya New Material TechnologyLtd 22.72% 63.29% ★★★★★★ PharmaResearch 24.38% 25.85% ★★★★★★ eWeLLLtd 24.95% 24.40% ★★★★★★ JNTC 54.24% 87.93% ★★★★★★ Click here to see the full list of 495 stocks from our Asian High Growth Tech and AI Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Shenzhen Kinwong Electronic Co., Ltd. is involved in the research, development, production, and sale of printed circuit boards and electronic materials both in China and internationally, with a market cap of approximately CN¥29.28 billion. Operations: Kinwong Electronic focuses on the production and sale of printed circuit boards, generating a revenue of CN¥13.26 billion from this segment. Shenzhen Kinwong Electronic has demonstrated robust growth metrics, with revenue climbing to CNY 3.34 billion this quarter from CNY 2.74 billion in the previous year, marking a significant increase of 21.9%. This performance is bolstered by an earnings growth of 23.7% per year, outpacing the broader Chinese market's average. The company's commitment to innovation is evidenced by its substantial R&D investment, which aligns with industry trends towards advanced electronic solutions and might signal sustained future growth amidst a competitive tech landscape. Moreover, recent corporate activities including their annual general meeting and quarterly earnings announcements reflect active engagement and transparency with stakeholders, enhancing investor confidence in their operational strategies and market position. Delve into the full analysis health report here for a deeper understanding of Shenzhen Kinwong Electronic. Gain insights into Shenzhen Kinwong Electronic's past trends and performance with our Past report. Simply Wall St Growth Rating: ★★★★★☆ Overview: Semitronix Corporation offers characterization and yield improvement solutions for the semiconductor industry both in China and internationally, with a market cap of CN¥11.49 billion. Operations: The company focuses on delivering solutions that enhance semiconductor characterization and yield, targeting both domestic and international markets. With a market capitalization of approximately CN¥11.49 billion, it operates within the semiconductor industry, providing specialized services aimed at optimizing production processes. Semitronix Corporation has shown a promising uptick in its financial health, with first-quarter sales jumping to CNY 66.48 million from CNY 43.9 million the previous year, reflecting a robust revenue growth rate of 51.7%. This performance is complemented by a significant reduction in net loss to CNY 13.71 million from CNY 22.9 million, indicating improving operational efficiency. The company's commitment to innovation and market adaptation is underscored by an R&D investment that aligns with evolving technological demands, positioning it well within the competitive landscape of Asia's high-growth tech sector. Get an in-depth perspective on Semitronix's performance by reading our health report here. Evaluate Semitronix's historical performance by accessing our past performance report. Simply Wall St Growth Rating: ★★★★★☆ Overview: Taiwan Union Technology Corporation specializes in producing and distributing copper foil substrates, adhesive sheets, and multi-layer laminated boards both domestically and internationally, with a market capitalization of NT$51.79 billion. Operations: The company focuses on manufacturing and selling copper foil substrates, adhesive sheets, and multi-layer laminated boards to both domestic and international markets. It operates with a market capitalization of NT$51.79 billion. Taiwan Union Technology has demonstrated robust financial performance, with a 44.3% increase in Q1 sales year-over-year, reaching TWD 6.37 billion. This growth is supported by a significant rise in net income to TWD 671.95 million from TWD 451.84 million, reflecting an earnings growth of about 48.7%. The company's strategic focus on R&D is evident from its recent presentations at major tech conferences, positioning it well for sustained innovation and market competitiveness within Asia's tech sector. Click here to discover the nuances of Taiwan Union Technology with our detailed analytical health report. Examine Taiwan Union Technology's past performance report to understand how it has performed in the past. Discover the full array of 495 Asian High Growth Tech and AI Stocks right here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:603228 SZSE:301095 and TPEX:6274. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
31 minutes ago
- Yahoo
Taysha Gene Therapies, Inc. (TSHA)'s TSHA-102 Shows Promising Results in Rett Syndrome Patients Aged 6+
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has announced pivotal progress in its TSHA-102 gene therapy program for Rett syndrome, following written alignment with the FDA on a single-arm, open-label pivotal trial targeting patients aged six and older. This population, shown by natural history data to have virtually zero chance of regaining developmental milestones, saw a 100% responder rate in the REVEAL Part A trial: all 10 treated patients gained or regained at least one developmental milestone post-TSHA-102, with high-dose recipients showing faster and deeper improvements. No serious adverse events or dose-limiting toxicities were reported. A scientist holding a Petri dish filled with a gene therapy sample. Taysha Gene Therapies, Inc. (NASDAQ:TSHA)'s pivotal Part B trial, expected to launch in Q3 2025, will enroll 15 females in the developmental plateau stage, using each patient as their own control and video-based, blinded milestone assessment as the primary endpoint. The FDA's support, based on robust longitudinal data from over 1,100 Rett patients, marks a major regulatory milestone. TSHA-102, a one-time AAV9 gene therapy delivering functional MECP2, is designed to address the genetic root cause of Rett syndrome, a devastating disorder with no current disease-modifying treatments. Taysha Gene Therapies, Inc. (NASDAQ:TSHA) will present further details at the IRSF Rett Syndrome Scientific Meeting in June. While we acknowledge the potential of TSHA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TSHA and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data